Funding kicks off new treatments for diabetes and multiple sclerosis

October 16, 2006

A $5.23 million research program that will combine stem cell therapies with a rebuilding of a key part of the immune system - the thymus - to treat diseases such as autoimmune gastritis, multiple sclerosis and diabetes is being pursued at Monash University following today's announcement that it has been funded through the National Health and Medical Research Council's Programs scheme.

The Minister for Health and Ageing, The Hon.Tony Abbott today announced funding for Monash University of more than $43 million through the NHMRC's Program, Project and Career Development schemes.

This included funding for nine Research Fellowships, two Practitioner Fellowships, two enabling grants - $2.5 million for the National Non-Human Primate Breeding and Research Facility and $1.84 million for the Australian Mouse Brain Mapping Consortium - and an $822,000 equipment grant.

Deputy Vice-Chancellor (Research) Professor Edwina Cornish said the NHMRC funding announced today was testament to the innovative medical research being pursued at Monash.

Professor Richard Boyd, principal investigator on the stem cell program, said diseases such as autoimmune gastritis, multiple sclerosis and diabetes arose because a "rogue" immune system had turned inwards to attack the body's organs. "The organ destruction follows from recognition by the immune system of specific molecules - insulin in the case of diabetes, and a protein called MOG in the case of MS - in the organs," Professor Boyd said.

"These "autoimmune" diseases are incurable and controlled mainly by long-term administration of substances that suppress the immune system, often with serious side-effects. A rational approach is to render the rogue immune system harmless by removing the immune cells that recognize these particular molecules," he said. "We plan to use stem cell therapies combined with a rejuvenated immune system to treat these diseases without the need for excessive immunosuppressive regimes that are detrimental to health and well-being."

The same technologies should be applicable to minimising or even preventing the rejection of foreign transplants, Professor Boyd said.

Other projects funded today that will be pursued at Monash include a study of Australian box jellyfish venoms, an investigation of whether coeliac disease causes a loss of coordination or cognitive impairment, the factors that affect knee structure in healthy women, and a trial of the effect of substantial weight loss on obstructive sleep apnoea.
-end-


Research Australia

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.